Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingqing Liu

Showing results (101-110 of 611) with videos related to

Pageof 62
Sort By:
Theriogenology|April 29, 2020
Overexpression of PGC7 in donor cells maintains the DNA methylation status of imprinted genes in goat embryos derived from somatic cell nuclear transfer technologyYufei Wang, Qingqing Liu, Jian Kang, et al.
Biochemical and Biophysical Research Communications|August 14, 2016
Dixdc1 targets CyclinD1 and p21 via PI3K pathway activation to promote Schwann cell proliferation after sciatic nerve crushWeijie Wu, Qingqing Liu, Yuxi Liu, et al.
Journal of Inflammation Research|February 26, 2025
IL-6 and CD4<sup>+</sup>/CD8<sup>+</sup> are Important Indicators for Predicting Prognosis in Elderly AECOPD Patients: A Retrospective StudyQingqing Liu, Yanhui Wang, Xueshuai Cao, et al.
Chaos (Woodbury, N.Y.)|October 5, 2013
Series-NonUniform Rational B-Spline (S-NURBS) model: a geometrical interpolation framework for chaotic dataChenxi Shao, Qingqing Liu, Tingting Wang, et al.
Clinical Rheumatology|October 18, 2018
Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regressionQingqing Liu, Jin Yang, Hairong He, et al.
Cancer Immunology, Immunotherapy : CII|August 26, 2020
The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinomaQingqing Liu, Shixian Hua, Xinyi Wang, et al.
European Journal of Medicinal Chemistry|December 26, 2021
Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathwayQingqing Liu, Bin Zhang, Yuanjiang Wang, et al.
Chemical Communications (Cambridge, England)|December 18, 2023
Isolated Ni-atom catalyst supported on Ti<sub>3</sub>C<sub>2</sub>T<sub></sub> with an asymmetrical C-Ni-N structure for the hydrogen evolution reactionHaosen Yang, Pengfei Wu, Jiajing Pei, et al.
International Journal of Molecular Sciences|August 12, 2023
Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular VesiclesJian Wang, Qingqing Liu, Yuanxin Zhao, et al.
Heliyon|October 9, 2023
Potential role of Chinese medicine nanoparticles to treat coronary artery diseaseRongyuan Yang, Yingming Gu, Jinying Qin, et al.
Pageof 62

Showing results (101-110 of 611) with videos related to

Sort By:
Pageof 62
Theriogenology|April 29, 2020
Overexpression of PGC7 in donor cells maintains the DNA methylation status of imprinted genes in goat embryos derived from somatic cell nuclear transfer technologyYufei Wang, Qingqing Liu, Jian Kang, et al.
Biochemical and Biophysical Research Communications|August 14, 2016
Dixdc1 targets CyclinD1 and p21 via PI3K pathway activation to promote Schwann cell proliferation after sciatic nerve crushWeijie Wu, Qingqing Liu, Yuxi Liu, et al.
Journal of Inflammation Research|February 26, 2025
IL-6 and CD4<sup>+</sup>/CD8<sup>+</sup> are Important Indicators for Predicting Prognosis in Elderly AECOPD Patients: A Retrospective StudyQingqing Liu, Yanhui Wang, Xueshuai Cao, et al.
Chaos (Woodbury, N.Y.)|October 5, 2013
Series-NonUniform Rational B-Spline (S-NURBS) model: a geometrical interpolation framework for chaotic dataChenxi Shao, Qingqing Liu, Tingting Wang, et al.
Clinical Rheumatology|October 18, 2018
Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regressionQingqing Liu, Jin Yang, Hairong He, et al.
Cancer Immunology, Immunotherapy : CII|August 26, 2020
The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinomaQingqing Liu, Shixian Hua, Xinyi Wang, et al.
European Journal of Medicinal Chemistry|December 26, 2021
Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathwayQingqing Liu, Bin Zhang, Yuanjiang Wang, et al.
Chemical Communications (Cambridge, England)|December 18, 2023
Isolated Ni-atom catalyst supported on Ti<sub>3</sub>C<sub>2</sub>T<sub></sub> with an asymmetrical C-Ni-N structure for the hydrogen evolution reactionHaosen Yang, Pengfei Wu, Jiajing Pei, et al.
International Journal of Molecular Sciences|August 12, 2023
Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular VesiclesJian Wang, Qingqing Liu, Yuanxin Zhao, et al.
Heliyon|October 9, 2023
Potential role of Chinese medicine nanoparticles to treat coronary artery diseaseRongyuan Yang, Yingming Gu, Jinying Qin, et al.
Pageof 62